Sort by

Send to

Choose Destination

Links from PubMed

Items: 11


Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder.

Kim SW, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M.

Psychiatry Investig. 2015 Jul;12(3):349-55. doi: 10.4306/pi.2015.12.3.349.


Psychosocial treatment and interventions for bipolar disorder: a systematic review.

Miziou S, Tsitsipa E, Moysidou S, Karavelas V, Dimelis D, Polyzoidou V, Fountoulakis KN.

Ann Gen Psychiatry. 2015 Jul 7;14:19. doi: 10.1186/s12991-015-0057-z.


Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity.

Bauer R, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Murray G, Ritter P, Lewitzka U, Severus E, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2013 Dec 9;1:26. doi: 10.1186/2194-7511-1-26.


The efficacy of psycho-educational group program on medication adherence and global functioning of patients with bipolar disorder type I.

Bahredar MJ, Asgharnejad Farid AA, Ghanizadeh A, Birashk B.

Int J Community Based Nurs Midwifery. 2014 Jan;2(1):12-9.


What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders.

Chakrabarti S.

World J Psychiatry. 2014 Jun 22;4(2):30-6. doi: 10.5498/wjp.v4.i2.30.


Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202.


Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why.

Gibson S, Brand SL, Burt S, Boden ZV, Benson O.

BMC Psychiatry. 2013 May 29;13:153. doi: 10.1186/1471-244X-13-153.


Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.

Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH.

J Clin Psychopharmacol. 2013 Jun;33(3):343-50. doi: 10.1097/JCP.0b013e3182900c6f.


Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.

Sajatovic M, Levin J, Tatsuoka C, Micula-Gondek W, Fuentes-Casiano E, Bialko CS, Cassidy KA.

Bipolar Disord. 2012 May;14(3):291-300. doi: 10.1111/j.1399-5618.2012.01010.x.


Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.

Gonzalez JM, Thompson PM, Moore TA.

Patient Prefer Adherence. 2011;5:333-41. doi: 10.2147/PPA.S10968.


Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder.

Morriss RK, Lobban F, Jones S, Riste L, Peters S, Roberts C, Davies L, Mayes D.

BMC Psychiatry. 2011 Jul 21;11:114. doi: 10.1186/1471-244X-11-114.

Items per page

Supplemental Content

Support Center